McKesson(US:MCK) ZACKSยท2024-09-26 23:05Company Performance - McKesson's stock closed at $479.06, reflecting a slight decrease of -0.02% from the previous day, underperforming compared to the S&P 500's gain of 0.4% [1] - Over the past month, McKesson shares have declined by 13.93%, which is significantly worse than the Medical sector's loss of 2.27% and the S&P 500's gain of 1.71% [1] - The upcoming earnings report is scheduled for November 6, 2024, with projected earnings per share (EPS) of $7.09, indicating a 13.8% increase year-over-year, and expected revenue of $89.57 billion, up 16% from the same quarter last year [1] Annual Forecast - The Zacks Consensus Estimates for the entire year predict earnings of $32.07 per share and revenue of $353.23 billion, representing increases of +16.87% and +14.33% respectively compared to the previous year [2] Analyst Estimates and Valuation - Recent changes in analyst estimates for McKesson reflect evolving short-term business trends, with positive revisions indicating analyst optimism about the company's profitability [2] - McKesson currently holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate having decreased by 0.1% in the past month [3] - The company is trading at a Forward P/E ratio of 14.94, which is lower than the industry average of 18.16, and has a PEG ratio of 1.12 compared to the industry average of 1.92 [3] Industry Context - The Medical - Dental Supplies industry, which includes McKesson, has a Zacks Industry Rank of 175, placing it in the bottom 31% of over 250 industries [4] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]